资讯

TMCnet

Positive Phase 3 Results for Denifanstat for the Treatment of Moderate to Severe Acne to be ...

Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, TVB-3567, for development in acne ...